Dr Reddy’s to acquire allergy brands from Glenmark

1 December 2020 - Deborah Wilkes

Premium

Indian pharmaceutical company Dr Reddy’s Laboratories is acquiring a portfolio of allergy remedies from Glenmark Pharmaceuticals in Russia, Ukraine, Kazakhstan and Uzbekistan.

Click tags below for more information on topics:

Dr Reddy's Glenmark

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: